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Background: Current available malaria diagnostic methods each have some limitations to meet the need for real-time
and large-scale screening of asymptomatic and low density malaria infection at community level. It was proposed that
malaria parasite-specific low molecular-weight metabolites could be used as biomarkers for the development of a
malaria diagnostic tool aimed to address this diagnostic challenge. In this study, high resolution metabolomics (HRM)
was employed to identify malaria parasite-specific metabolites in Plasmodium falciparum in vitro culture samples.
Methods: Supernatants were collected at 12 hours interval from 3% haematocrit in vitro 48-hour time-course
asynchronized culture system of P. falciparum. Liquid chromatography coupled with high resolution mass
spectrometry was applied to discover potential parasite-specific metabolites in the cell culture supernatant. A
metabolome-wide association study was performed to extract metabolites using Manhattan plot with false discovery
rate (FDR) and hierarchical cluster analysis. The significant metabolites based on FDR cutoff were annotated using
Metlin database. Standard curves were created using corresponding chemical compounds to accurately quantify
potential Plasmodium-specific metabolites in culture supernatants.
Results: The number of significant metabolite features was 1025 in the supernatant of the Plasmodium infected culture
based on Manhattan plot with FDR q=0.05. A two way hierarchical cluster analysis showed a clear segregation of the
metabolic profile of parasite infected supernatant from non-infected supernatant at four time points during the 48 hour
culture. Among the 1025 annotated metabolites, the intensities of four molecules were significantly increased with
culture time suggesting a positive association between the quantity of these molecules and level of parasitaemia: i)
3-methylindole, a mosquito attractant, ii) succinylacetone, a haem biosynthesis inhibitor, iii) S-methyl-L-thiocitrulline, a
nitric oxide synthase inhibitor, and iv) O-arachidonoyl glycidol, a fatty acid amide hydrolase inhibitor, The highest
concentrations of 3-methylindole and succinylacetone were 178 ± 18.7 pmoles at 36 hours and 157±30.5 pmoles at
48 hours respectively in parasite infected supernatant.
Conclusion: HRM with bioinformatics identified four potential parasite-specific metabolite biomarkers using in vitro
culture supernatants. Further study in malaria infected human is needed to determine presence of the molecules
and its relationship with parasite densities.
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Among four species of human malaria parasites, Plasmo-
dium falciparum is responsible for most malaria-
attributed morbidity and mortality. Over the past decade,
successful scale-up of malaria control has resulted in
substantial reductions in malaria cases and deaths [1,2].
As malaria transmission decreases due to control ef-
forts, the epidemiology of malaria may change; that is,
an increasing proportion of infections at the community
level may be asymptomatic and of low parasite density
[3,4]. Current malaria diagnostic tools include: 1) para-
site detection by microscopic examination of blood
smears, 2) antigen-based rapid diagnostic tests (RDTs),
and 3) sensitive DNA-based assays. All these diagnostic
methods require blood sampling by finger-prick and
their implementation has been limited by either their
labour/time intensive nature and requirement for special-
ized training and skills (microscopic method), moderate
sensitivity (RDTs, microscopy), or high cost of sample
preparation and supporting infrastructure needed (DNA-
based methods). For programmes aiming to reduce
transmission by further decreasing the parasite reser-
voir in humans through large scale screening approaches
to detect and then to radically cure asymptomatic low-
density malaria infections in real time, a field-deployable
non-invasive, sensitive, low-cost, simple diagnostic tool
would be very useful at the community level. Currently,
available diagnostic tools cannot meet this challenge.
Therefore, it was proposed to identify malaria parasite-
specific low molecular-weight metabolites that could
potentially be used for future development of such diag-
nostic tools.
As the first step for proof of concept, this study was
designed to identify parasite specific low molecular-
weight metabolites in an in vitro 48-hour time-course
culture system of P. falciparum using high-resolution
metabolomics (HRM) [5-7]. Earlier metabolomic studies
on malaria have mainly focused on metabolic pathways
and enzymes for the development of therapeutic strat-
egies and interpretation of malaria pathogenesis. For ex-
ample, using metabolomics with LC-MS/MS, Olszewski
et al. identified the potential mechanism of cerebral mal-
aria pathogenesis which was associated with the deple-
tion of arginine [8]. More recently, NMR techniques in
malaria metabolite profiling has been applied to identify
biomarkers for infections. Tritten et al. identified two
urinary metabolites in Plasmodium berghei infected
mice, while a study by Sengupta et al. suggested urinary
ornithine seems to have the potential as biomarkers of
Plasmodium vivax malaria [9,10]. Although the two
studies were conducted in rodent malaria and P. vivax
malaria respectively, their analytical approaches could be
used in mining for biomarkers of P. falciparum malaria
infection. A study by Teng et al. showed strain-specificdifferences in a range of metabolites in erythrocytes in-
fected with P. falciparum from in vitro culture and fur-
ther highlighted the variation in levels of choline and
phosphocholine among the strains [11]. In addition,
Sana et al. investigated global mass spectrometry-based
metabolomic profiling between in vitro P. falciparum in-
fected and uninfected erythrocytes [12]. They demon-
strated the alteration of metabolic profiling including the
glycolysis pathway and tricarboxylic acid (TCA) cycle
elucidating the mechanism of host-parasite interactions.
In contrast to the above reports, this study was de-
signed to explore P. falciparum specific waste products,
low molecular-weight metabolites, in the supernatant
from the erythrocyte culture system. The rationale for
profiling low molecular-weight metabolites in culture
supernatants, first, was based on the hypothesis that
parasite-specific small molecular wastes could be se-
creted into urine, saliva or sweat at high concentrations
in malaria infected human and the ultimate goal is to
use the small molecules as potential biomarkers for de-
velopment of non-invasive and sensitive malaria diag-
nostic tools. This study demonstrated HRM could
achieve a relatively comprehensive and quantitative ana-
lysis of Plasmodium-specific metabolites in supernatant
from parasite infected culture system, and explores low




In this study, asynchronized culture was employed. The
purpose of using asynchronized culture was to capture
small metabolite molecules that might be commonly re-
leased by all stages of parasites. The laboratory-adapted
3D7 strain of P. falciparum was used. The asynchronized
blood stage parasites were cultured as described [14] in
RPMI 1640 medium supplemented with 10% heat-
inactivated O+ human serum, 1 ug/ml gentamicin, 36 uM
hypoxanthine, 31 mM HEPES and 25 mM sodium bicar-
bonate. Four flasks of parasite culture with 3% haemato-
crit and 0.5% starting parasitaemia were prepared at the
same time using red blood cells from different donors.
At the same time, four flasks of culture without parasite
inoculation but containing the same culture medium
and haematocrit were also prepared. Culture materials,
including supernatants and cell pellets, from all the in-
fected and not infected flasks were collected at 12, 24,
36, and 48 hours without changing and adding culture
medium. In total, 16 supernatant samples obtained from
the infected flasks and the same numbers of supernatant
samples from non-infected flasks were used for this
study. All the samples used in this study were myco-
plasma free. Parasite densities in the infected flasks were
recorded as % count by blood smear reading. They
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0.20% and 2.38%±0.30% (mean±SD) at 12, 24, 36 and
48 hours, respectively.
The application of C18 liquid chromatography coupled
with Fourier-Transform Mass Spectrometry (FTMS)
All the samples were run in duplicate. One hundred μl
aliquots of supernatant samples were treated with aceto-
nitrile (2:1, v/v), spiked with 2.5 μl internal standard
mix, and centrifuged at 14,000 × g for 5 minutes at 4°C
to remove protein as described previously [15]. Then
LTQ-FTMS (Thermo, hybrid linear ion trap-Fourier
Transform Ion Cyclotron Resonance mass spectrometry,
MA, USA) coupled with C18 liquid chromatography was
run on those collected samples. HRM offers an import-
ant advantage in analysis of highly complex metabolite
mixtures, such as biological extracts, because detection
of mass/charge (m/z) with 5 ppm or better mass reso-
lution and mass accuracy substantially decreases the
demand for physical separation prior to detection. De-
tection of m/z of ions from 85 to 850 with 50,000 reso-
lution over 10 min LC runs with data extraction using
apLCMS [16] provides a minimum of 3,000 reproducible
features, many with sufficient mass accuracy to allow
prediction of elemental composition. A m/z feature is
defined by m/z, RT (retention time), and ion intensity
(integrated ion intensity for the peak). The Kyoto
Encyclopedia of Genes and Genomes (KEGG) database
[17] was utilized to map the features distribution on
both human and Plasmodium metabolic pathways.
Examination of m/z of metabolites in the KEGG [18,19]
human and Plasmodium metabolomics pathways shows
that less than 10% of metabolites are redundant with
others in terms of elemental composition [18,19]. Identi-
fied metabolites are annotated using Metlin Mass Spec-
trometry Database [20,21]. Direct examination by MS/
MS of selected accurate mass m/z features of human
plasma showed that for many m/z, the ion dissociation
patterns matched those of authentic standards with
identical elution times. For such metabolites, quantifica-
tion relative to stable isotope internal standards has a
coefficient of variation (5 to 10%) and sensitivity (low
nanomolar to picomolar), which is similar to other
methods and sufficient in allowing targeted analysis of
selected chemicals within the context of an information-
rich non-targeted profiling of all m/z detected within
biological samples.
Metabolic profiling with univariate and multivariate
statistical analysis
Analyses were performed based on the results from both
biological and technical replicates. Total features of cul-
ture supernatant were collected after processing mass
spectral data with apLCMS. The features from duplicateLCMS analyses were averaged, log2 transformed and
quantile normalized for subsequent statistical and bioinfor-
matics analyses including univariate analysis, Manhattan
plot, and false discovery rate (FDR) [22] to determine the
significant metabolites between infected and non-infected
cultures. Furthermore, the metabolic profiles were discrimi-
nated using Limma-hierarchical cluster analysis to separate
two groups in association with metabolites. Limma is
originally a package of Linear Models for Microarray to
analyse the gene expression data arising from micro-
array or RNA-Seq technologies from Bioconductor. A
core capability is the use of linear models to assess dif-
ferential expression in the context of multifactor de-
signed experiments. Limma provides the ability to make
comparisons between many targets simultaneously in-
cluding metabolites [23,24].
Pathway analysis with KEGG
The database of Kyoto Encyclopedia of Genes and Ge-
nomes (KEGG) was utilized to map the features distribu-
tion on both human and plasmodium metabolic pathways.
Detected m/z features matching known human and Plas-
modium intermediary metabolites are shown in black dots
in pathway maps; most human and known Plasmodium
metabolic pathways are represented.
Quantification of 3-methylindole and succinylacetone
3-methylindole (M51458) and succinylacetone (D1415)
were purchased from Sigma-Aldrich (MO, USA). A
standard curve was made by known concentrations
(0.1-0.5nmole) of the reagent grade compounds in cell
culture media. Areas from the samples were plotted
against concentrations and a standard curve with an
r2>0.99. 3-methylindole and succinylacetone in super-
natants from parasite culture were treated using 100 μl
in microcentrifuge tubes. These tubes were centrifuged
at 14,000× g at 4 degrees Celsius for 5 minutes. 10 μl
of the supernatant was injected in mass spectrometry
and resulting areas were noted. Concentrations of the
compounds were calculated using the standard curve.
Results
Metabolome-wide association study (MWAS)
MWAS was used to identify changes in supernatants
from non-infected and Plasmodium-infected cultures at
all points (12, 24, 36, and 48 hrs). A Manhattan plot
(Figure 1) combines a statistical test (e.g., p-value,
ANOVA) with the magnitude of change and enables vis-
ual identification of statistically significant data-points
(metabolites) that display large-magnitude changes. Mul-
tiple testing corrections like FDR adjusts p-values (q-values)
derived from multiple statistical tests to correct for the oc-
currence of false positives. The Y axis represents the -log10
of the raw p-value comparing supernatants of culture
Figure 1 Metabolome-wide association study (MWAS). This is the snapshot of metabolites between supernatants from Plasmodium, non-
infected and infected cultures at all time points using Manhattan plot on 3270 features. The features from duplicate run were averaged, log2
transformed, and quantile normalized to find out the significant features using false discovery rate (FDR). The dotted line represents FDR q=0.05.
The metabolites over this line were the significant metabolites (n=1025) between two groups.
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red blood cells. The X axis indicated m/z ranging
85-850 m/z. The dotted line was shown as the FDR sig-
nificant level, therefore, any m/z above this line were sig-
nificantly different between two groups at FDR q=0.05.
The total number of significant features was 1025 out of
the 3270 detected.
Mapping significant features through Kyoto Encyclopedia
of Genes and Genomes (KEGG) human and plasmodium
metabolic pathways
HRM platform provides precise metabolic phenotypes to
determine the possible pathways altered by P. falcip-
arum. The schematic representation in Additional files 1
and 2 shows that FDR significant 1025 features covering
malaria parasite waste chemicals and human metabolites
from supernatants were mapped through KEGG both
human and Plasmodium metabolic pathways. Results
show that these metabolites matched 439 metabolic
compounds in both human and Plasmodium metabolic
pathways. The remaining 586 of 1025 chemicals which
were not matched, however, might be either waste prod-
ucts of the parasite or could be utilized by unidentified
Plasmodium pathways.
Two way hierarchical cluster analysis (HCA) on FDR
significant features in supernatant between non-infected
and infected cultures
Two way HCA was performed on combined sample clas-
sification with metabolites clustering to identify which
metabolites are the most important for sample grouping.
In this study, HCA was performed using 1025 metabolites
at FDR q=0.05, which were the key components to separ-
ate two groups using all four time points (Figure 2). HCA
determines similarity measures using Euclidean distance
and Pearson linear correlation. The top panel showed thattwo main clusters separating supernatant of non-infected
from infected cultures. The sample name was listed at the
bottom panel. The right panel included 1025 metabolites
which contributed to discrimination of samples according
to malaria infection. In addition, Figure 3 shows a broad
increasing trend in significant features at FDR q=0.05 dur-
ing 48 hours.
Decrease in arginine and isoleucine in the agreement
with others’ results
In order to validate methodology and analytical approach
used for the identification of candidate biomarker mole-
cules, the intensity of arginine and isoleucine known to be
consumed and critical for malaria parasite growth were
analysed. Amino acids are the building blocks of proteins.
As parasites grow within host red blood cells, they utilize
large quantities of amino acids. The malaria parasite de-
rives most of its amino acid requirements from the pro-
teolysed haemoglobin in the host blood cells [25]. In
Figure 4A, arginine decreased to zero in a time dependent
fashion during 48 hours. Most importantly, hemoglobin
lacks one important amino acid, isoleucine, and the para-
site, therefore, has to source this from culture system. In
Figure 4B, isoleucine was reduced significantly in superna-
tants after the 48 hour incubation period.
Identification of the potential biomarkers increased with
culture time
Among the remaining 586 of 1025 significant metabolites
(FDR q=0.05) determined by FDR, the ion intensities
of several metabolites were increased with culture time
in infected culture supernatants but not in non-
infected culture supernatants, suggesting a positive associ-
ation between the quantity of these molecules released
and level of parasitaemia. These metabolites were: i) 3-
methylindole (Figure 5A), ii) succinylacetone (Figure 5B),
Figure 2 Two way hierarchical cluster analysis (HCA) on FDR significant features of supernatants between non-infected and infected
cultures. HCA was performed using the 1025 metabolites at FDR q=0.05. The analysis utilized the samples from all time points to separate two
groups in top bar (red clusters for control samples, green clusters for infected samples).
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arachidonoyl glycidol (Figure 5D). The compound 3-
methylindole has been shown to stimulate an odorant
receptor to attract malaria mosquito vector [26] while
succinylacetone has been identified as an inhibitor of
haem biosynthesis [27,28]. S-methyl-L-thiocitrulline has
been identified as a potent nitric oxide synthase (NOS)Figure 3 The number of significant features using FDR q=0.05
at each time point during 48 hours’ culture.inhibitor to reduce nitric oxide production and endothelial
dysfunction [29]. On the other hand, O-arachidonoyl gly-
cidol was reported to be an inhibitor of fatty acid amide
hydrolase [30,31]. In addition, a similar pattern was ob-
served for phosphocholine (Additional file 3), the mol-
ecule that was reported in previous study using infected
erythrocytes [11] and is involved in the phosphobase
methylation for phosphatidylcholine production [32]. The
observed increase in phosphocholine with culture time
further validated our methodology and analytical approach
for identifying the four molecules reported above.
The quantification of 3-methylindole and succinylacetone
The production of 3-methylindole and succinylacetone
were measured at each time point during 48 hours in
the 50 μl of supernatants from 3% haematocrit cultures.
At 36 hours, the amount of 3-methylindole was highest
and the concentration was 178±18.7 pmoles (Figure 6A).
The generation of succinylacetone increased over the
time. The amounts were 2±2 pmoles at 12 hours culture,
with the highest reading at 157±30.5 pmoles at 48 hours
Figure 4 Decrease of arginine and isoleucine concentration during 48 hours’ culture. Figure 4A: Arginine, and Figure 4B: Isoleucine. White
bars indicated supernatants from Plasmodium non-infected culture and black bar represented as supernatants from Plasmodium infected culture.
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with the MS/MS data of these compounds found in
Additional files 4, 5, 6 and 7.
Discussion
The primary objective of this study was to explore P. fal-
ciparum-specific low molecular-weight metabolites that
can be used as biomarkers for future development of non-
invasive malaria diagnostic tools. Using the supernatant
samples from in vitro erythrocytic stage asynchronized
cultures, four molecules, 3-methylindole, succinylacetone,
S-methyl-L-thiocitrulline and O-arachidonoyl glycidol,
were identified as potential biomarkers.
Use of HRM is a uniquely good approach to identify
putative biomarkers for a complex disease like malaria
since Plasmodium parasites divert nutrients towardFigure 5 Increase in concentrations of four molecules during 48 hour
Figure 5C: S-methyl-L-thiocitrulline, and Figure 5D: O-arachidonoyl glycidol
culture and black bar represented as supernatants from Plasmodium infecteproliferating parasite cells while the host cells try to main-
tain homeostasis and deal with metabolic changes during
the parasites’ intraerythrocytic life cycle [33,34]. This
study demonstrated the strength of HRM in measuring P.
falciparum specific waste products and toxins which were
expected to increase in concentration during the infection.
Therefore, this approach allows for the identification of
potential biomarkers associated with Plasmodium-specific
products. Previous studies also showed that the analytic
capabilities of HRM could measure the relative levels of
all metabolites simultaneously in in vitro and in vivo mal-
aria infection systems [12]. Furthermore, using the out-
comes of HRM, KEGG mapping was performed in this
study. Significant features (n=1025) were identified in both
human and Plasmodium metabolic pathways to distin-
guish which metabolic compounds are being utilized bys’ culture. Figure 5A: 3-methylindole, Figure 5B: succinylacetone,
. White bars indicated supernatants from Plasmodium non-infected
d culture.
Figure 6 The quantification of 3-methylindole and succinylacetone at each time point during 48 hours’ culture. Figure 6A: Boxplot of
3-methylindole, and Figure 6B: Boxplot of succinylacetone.
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in both human and plasmodium metabolic pathways.
However, despite the similarities in this large number of
metabolites, the pathways in which these metabolites are
mapped are likely to be different due to the absence of
certain metabolic pathways in plasmodium compared to
human metabolic pathways. Meanwhile, of the 586 un-
matched features, four (4) were found to be potential bio-
markers from the parasite during the erythrocytic stage
culture system. This was based on the fact that the ion in-
tensities of the four molecules were increased with culture
time, suggesting a positive association between relative
quantity of these molecules and level of parasitaemia. In
addition, 3-methylindole and succinylacetone molecules
in the supernatant samples from 3% haematocrit 48 hour
time-course cultures were further quantified. The concen-
tration of succinylacetone peaked at 48 hours compared
to 36 hours for 3-methylindole. As 3-methylindole is vola-
tile molecule, it is possible that 3-methylindole was evapo-
rated due to extended culture to 48 hours. Importantly,
3-methylindole has been shown to stimulate an odorant
receptor to attract malaria mosquito vector [26], poten-
tially playing a role in enhancing the probability of trans-
mission for the parasite. Practically, 3-methylindole could
be used in traps for mosquito research purposes. Although
3-methylindole is found in large intestine of humans via
ingestion of tryptophan, this molecule is well-known as a
highly selective pulmonary toxicant for ruminants [35]. A
study showed that metabolism and bioactivation of 3-
methylindole in human is mediated by human liver micro-
somes [36]. In spite of the fact that this molecule is found
in human gastrointestinal system, it is probable that the
elevation of this molecule due to malaria infection in hu-
man could still be used as a potential biomarker when
urine or sweat samples are tested.
Another potential biomarker identified was succinylace-
tone which is known to inhibit haem biosynthesis (delta-
aminolevulinate dehydrolase inhibitor) [37]. Succinylacetoneeither makes the haem synthesizing system nonfunctional
or decreases its functionality [37]. Although this molecule
has been shown to be a biomarker for Tyrosinaemia Type 1
(Tyr I), the genetic disorder is rare and worldwide preva-
lence is very low. Therefore, utilizing this compound as a
potential biomarker in malaria-endemic areas could ac-
count for the malaria infection rather than the Tyr I. The
production range of succinylacetone suggests it may be use-
ful as a basis for developing a biosensor for non-invasive
diagnosis of malaria. Two other potential metabolites were
also identified in this study: S-methyl-L-thiocitrulline is a
potent NOS inhibitor to reduce nitric oxide production and
endothelial dysfunction [38] while O-arachidonoyl glycidol
was reported to be an inhibitor of fatty acid amide
hydrolase [30]. The increase in ion intensities during
culture period for these two molecules indicated a po-
tential as biomarkers for malaria diagnosis. Currently, a
metabolomics study using urine, saliva, sweat and blood
samples collected from P. falciparum infected people
from Africa is underway. The ongoing study will provide
information on concentration and stability of the mole-
cules in malaria infected people and their association
with parasite densities.
An apparent disappearance of two amino acids, argin-
ine and isoleucine, was observed in the 48 hr culture
system. Several important host-parasite interaction stud-
ies elucidated a mechanism that isoleucine was taken by
Plasmodium sp. to develop blood stage parasites [25,39].
Malaria parasite utilizes amino acids largely through the
degradation of host erythrocyte haemoglobin [40]. Isoleu-
cine is the only amino acid not present in human mature
haemoglobin, resulting in utilization of this amino acid
from other sources by parasites. The untargeted HRM
confirmed previous finding regarding the depletion of iso-
leucine in culture supernatant in time dependent manner,
supporting the reliability of experimental system and ana-
lytical approach in identifying the above four parasite-
specific waste metabolites and toxins which were released
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centration during 48 hr culture period.
In summary, HRM coupled with network and pathway
analysis using the significant metabolites from culture
supernatants of infected erythrocytes and incorporating
the broader human and malaria parasite metabolomic
knowledge identified four potential parasite-specific bio-
markers. The findings from the current study may pro-
vide improved opportunities for innovative prevention
and management programmes such as development of
new malaria diagnostic tools.
Additional files
Additional file 1: Mapping significant features to Kyoto
Encyclopedia of Genes andGenomes (KEGG) human metabolic
pathways. This schematic representation shows the mapping of 439
matched features covering human metabolites.
Additional file 2: Mapping significant features to Kyoto
Encyclopedia of Genes and Genomes (KEGG) Plasmodium metabolic
pathways. This schematic representation shows the mapping of 439
matched features covering malaria parasite metabolites.
Additional file 3: Increase in phosphocholine concentration during 48
hours culture. White bars indicated supernatants from Plasmodium
non-infected culture and black bar represented as supernatants from
Plasmodium infected culture.
Additional file 4: Spectrum of 3-methylindole itself. A) Total ion
chromatography, B) MS, and C) MS/MS.
Additional file 5: Spectrum of 3-methylindole after its addition to
cell supernatant. A) Total ion chromatography, B) MS, and C) MS/MS.
Additional file 6: Spectrum of 3-methylindole in cell supernatant.
A) Total ion chromatography, B) MS, and C) MS/MS.
Additional file 7: Spectrum of succinylacetone. A) Total ion
chromatography, B) MS on itself, C) MS/MS on itself, D) MS/MS after its
addition to cell supernatant, and E) MS/MS on cell supernatant without
chemical addition.
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